Work

Efficacité clinique de Cladribine comprimés (CC) chez les patients atteints de récurrente-rémittente (SEP-RR) : résultats finaux de l’étude d’extension de Phase IIIb à 120 semaines de l’étude CLARITY

Year: 2017

Type: article

Study design: Clinical Trial

Source: Revue Neurologique

DOI: 10.1016/j.neurol.2017.01.205

Authors: Gavin Giovannoni, Patrick Vermersch, Emilie Martin, Fernando Dangond

Institutions: Queen Mary University of London, Centre Hospitalier Universitaire de Lille, Merck Healthcare KGaA, Darmstadt (Germany)

Language: French

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2592679059

FWCI:

Cites:

Cited by:

Related to: 10